Menu
Back to User profile » Mr Zbigniew Kadziola
Papers published by Mr Zbigniew Kadziola:
Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario
Bereza BG, Coyle D, So DY, Kadziola Z, Wells G, Grootendorst P, Papadimitropoulos EA
ClinicoEconomics and Outcomes Research 2020, 12:167-175
Published Date: 19 March 2020
The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database
Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W
ClinicoEconomics and Outcomes Research 2016, 8:387-395
Published Date: 2 August 2016
Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
Montgomery W, Kadziola Z, Ye W, Xue HB, Liu L, Treuer T
Neuropsychiatric Disease and Treatment 2015, 11:177-183
Published Date: 19 January 2015
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
Ye W, Montgomery W, Kadziola Z, Liu L, Xue H, Stensland MD, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:869-878
Published Date: 16 May 2014
Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM
Patient Preference and Adherence 2013, 7:463-470
Published Date: 27 May 2013